Medical Technologist

Job Summary

BASIC

SUMMARY:

Perform basic medical technology procedures according to protocol, SOP and GLP. Operate, maintain and perform basic troubleshooting procedures on analyzers. Process additional study samples. Perform and review study ordered parameters and computer input of raw data.

• Assist in the preparation of appropriate paperwork and materials prior to clinical pathology blood collection days. Assist with the computer protocol work schedule for each study, as needed.
• Perform basic medical technology procedures such as record blood slide differentials, reticulocyte counts, and urinalysis with minimal supervision; prepare blood and cytology slide smears.
• Inventory and package differential and reticulocyte blood slides for each study for shipment or storage.
• Maintain proficient knowledge of hematology, clinical chemistry, coagulation, and urinalysis.
• Analyze proficiency survey samples.
• Review documentation of functions performed as part of quality requirements.
• Input raw data into the computer system and review data.
• Operate, maintain, and troubleshoot clinical pathology analyzers.
• Perform daily maintenance and quality control of instruments.
• Perform all other related duties as assigned.

• Education: Associate’s degree (A.A./A.S.) or equivalent in medical laboratory technology (MLT) or related field required. Bachelor’s degree (B.A./B.S.) or equivalent in medical technology (MT) desired.
• Experience: 2-3 years of experience in a clinical pathology laboratory.
• An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above.
• Certification/Licensure: MT or MLT with certification or certification-eligible (ASCP or HEW) preferred.
• Other: Experience with computer software programs is desirable. Effective organizational and leadership skills desired.

The pay range for this position is $ an hour.

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.

Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities.

Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 20,000 employees within 110 facilities in over 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly worked on 80% of the drugs approved by the U.S. Food and Drug Administration (FDA) in the past five years.

We’re committed to…